Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease

C Papadopoulos, D Orlikowski, H Prigent… - Molecular Genetics and …, 2017 - Elsevier
Background The efficacy of enzyme replacement therapy (ERT) in patients at an advanced
stage of Pompe disease has only been addressed in a few studies. Our objective was to …
被引用次数：32 相关文章

[引用][C] Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease

C Papadopoulos, D Orlikowski, H Prigent… - MOLECULAR …, 2017 - research.unipd.it

Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease

C Papadopoulos, D Orlikowski… - Molecular genetics …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The efficacy of enzyme replacement therapy (ERT) in patients at an advanced
stage of Pompe disease has only been addressed in a few studies. Our objective was to …

Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease.

C Papadopoulos, D Orlikowski, H Prigent… - Molecular Genetics …, 2017 - europepmc.org
Background The efficacy of enzyme replacement therapy (ERT) in patients at an advanced
stage of Pompe disease has only been addressed in a few studies. Our objective was to …

Effect of enzyme replacement therapy with alglucosidase alfa (myozyme (r)) in 12 patients with advanced late-onset pompe disease

C Papadopoulos, D Orlikowsld, H Prigent, A Lacour… - 2017 - lilloa.univ-lille.fr
Effect of enzyme replacement therapy with alglucosidase alfa (myozyme (r)) in 12 patients with
advanced late-onset pompe disease Toggle navigation English français Aide | Contact | À …

Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease

C Papadopoulos, D Orlikowski, H Prigent… - Molecular Genetics and …, 2017 - infona.pl
The efficacy of enzyme replacement therapy (ERT) in patients at an advanced stage of
Pompe disease has only been addressed in a few studies. Our objective was to assess the …

Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme (R)) in 12 patients with advanced late-onset Pompe disease

C Papadopoulos, D Orlikowski, H Prigent… - Molecular Genetics …, 2017 - hal.univ-lille.fr
The efficacy of enzyme replacement therapy (ERT) in patients at an advanced stage of
Pompe disease has only been addressed in a few studies. Our objective was to assess the …
[PDF] academia.edu

[PDF][PDF] Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease

C Papadopoulos, D Orlikowski, H Prigent, A Lacour… - 2017 - academia.edu
Background: The efficacy of enzyme replacement therapy (ERT) in patients at an advanced
stage of Pompe disease has only been addressed in a few studies. Our objective was to …

Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme (R)) in 12 patients with advanced late-onset Pompe disease

C Papadopoulos, D Orlikowski, H Prigent, A Lacour… - 2017 - lilloa.univ-lille.fr
Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme (R)) in 12 patients
with advanced late-onset Pompe disease Toggle navigation English français Aide | Contact | À …